Done Global Inc. Company Profile

Background

Company Overview

Done Global Inc., established in 2019, is a San Francisco-based telehealth provider specializing in the diagnosis and treatment of Attention Deficit Hyperactivity Disorder (ADHD) and other chronic psychiatric conditions. The company offers virtual consultations, connecting patients with clinicians who may prescribe medications such as Adderall, Ritalin (methylphenidate), and Vyvanse (lisdexamfetamine). Additionally, Done provides digital therapies and support systems to deliver comprehensive mental health care to its patients.

Mission and Vision

Done's mission is to make high-quality psychiatric chronic ADHD care management more accessible and affordable for patients. The company aims to empower individuals living with ADHD to reach their fullest potential by providing personalized online treatment and support.

Key Strategic Focus

Core Objectives

Done focuses on delivering accessible and affordable psychiatric care through a hybrid model that combines virtual and in-person appointments. The company's primary objective is to streamline the diagnosis and treatment process for ADHD, ensuring patients receive timely and effective care.

Areas of Specialization

The company specializes in ADHD treatment management, offering services such as online ADHD testing, medication prescriptions, and ongoing care. Done integrates digital therapies and support systems to provide comprehensive mental health services.

Key Technologies Utilized

Done leverages telehealth platforms to facilitate virtual consultations, enabling patients to connect with clinicians remotely. The company also utilizes digital tools for therapy and support, enhancing the overall patient experience.

Primary Markets Targeted

Done primarily targets individuals seeking ADHD diagnosis and treatment, offering services that cater to patients' needs for convenience and affordability. The company's telehealth model allows it to reach a broad audience, including those in underserved areas.

Financials and Funding

Funding History

Done has secured funding from investors such as Craft Ventures, F7 Ventures, and Offline Ventures. The company closed its last funding round on September 23, 2020, from a Seed round.

Revenue

Estimates of Done's annual revenue vary:

$114.8 million per year, with an estimated revenue per employee of $337,500.

$4.1 million, with 50 employees.

$1.7 million in 2024.

Intended Utilization of Capital

The capital raised has been intended to expand Done's telehealth services, enhance its technological platforms, and increase its reach to patients seeking ADHD treatment.

Pipeline Development

Key Services

Done offers a range of services, including:

Online ADHD Testing: Initial online self-assessment for ADHD, followed by appointments with specialized medical providers for official diagnosis.

ADHD Medication Prescription: Prescriptions for ADHD medications, including both stimulant and non-stimulant options, after thorough assessment by licensed clinicians.

Ongoing ADHD Care: Online visits, worry-free refills, and 24/7 access to clinicians and care teams for continuous ADHD management.

Development Stages and Timelines

As a telehealth provider, Done continuously develops and refines its services to meet patient needs. Specific timelines for service enhancements are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

Done utilizes a proprietary telehealth platform that facilitates virtual consultations, digital therapies, and support systems, enabling comprehensive mental health care delivery.

Significant Scientific Methods

The company employs evidence-based clinical protocols for ADHD diagnosis and treatment, ensuring that patients receive care aligned with current medical standards.

Leadership Team

Key Executives

Ruthia He: Founder and Chief Executive Officer. Prior to founding Done, she was a product designer at Facebook.

David Brody: Clinical President of Done Health P.C.

Key Contributions

Under their leadership, Done has expanded its telehealth services, focusing on making ADHD care more accessible and affordable.

Leadership Changes

In June 2024, the U.S. Department of Justice charged Ruthia He and David Brody with distributing controlled substances via telemedicine, healthcare fraud, and obstruction of justice. These charges have led to significant leadership changes within the company.

Competitor Profile

Market Insights and Dynamics

The telehealth industry has experienced rapid growth, particularly during the COVID-19 pandemic, as patients and providers sought remote healthcare solutions. The market for online ADHD treatment has become increasingly competitive, with several companies offering similar services.

Competitor Analysis

Key competitors in the online ADHD treatment space include:

Cerebral: Offers virtual therapy and medication management for various mental health conditions, including ADHD.

AbleTo: Provides virtual behavioral health therapy and coaching programs.

PocDoc: Offers digital health solutions, including remote diagnostics and treatment plans.

These competitors focus on providing accessible mental health care through telehealth platforms, similar to Done's service offerings.

Strategic Collaborations and Partnerships

Done collaborates with a network of pharmacies to streamline medication management and ensure timely access to prescribed treatments. These partnerships are integral to the company's telehealth model, facilitating efficient service delivery.

Operational Insights

Strategic Considerations

Done's telehealth model offers distinct competitive advantages, including convenience, affordability, and accessibility. By focusing on ADHD treatment, the company addresses a specific market need, differentiating itself from competitors with broader mental health service offerings.

Strategic Opportunities and Future Directions

Strategic Roadmap

Despite recent legal challenges, Done has the opportunity to refine its service delivery, enhance compliance measures, and rebuild trust with patients and partners.

Opportunities for Expansion

Expanding service offerings to include additional mental health conditions and integrating advanced digital therapies could position Done for future growth.

Positioning for Future Objectives

Leveraging its technological platform and focusing on patient-centric care will be crucial for Done to achieve its future objectives in the evolving telehealth landscape.